Modelling group
at the Department of Medical Biometry, University of Tübingen

français deutsch
About us

Research
Influenza
Emerging diseases
Smallpox
Measles
Poliomyelitis
Malaria
Onchocerciasis
Filariases
  Introduction
  Eradicability
       Summary
       Pesistence graph
       Uncertainties
       Limitation and control
       Limitation
       Facilitation
  Model
  Dispersion patterns
  Glossary
Leishmaniasis
Haemophilus
Pneumococci
Others

Methods

Publications

Public Relations

Impressum

Glossary


ABR: Annual biting rate (number of vectors that take a blood meal on one human host per year).

ATP: Annual transmission potential [average number of infectious larvae (L3) transmitted to one human host per year].

Breakpoint: A parasite number or density below which infection cannot persist. Breakpoints can be determined for each parasite stage and also for the ATP; they represent ABR-specific, unstable equilibria, resulting from facilitation processes. Breakpoints guarantee the existence of a stable zero equilibrium which is a prerequisite of stable elimination (if there are no breakpoints and the ABR exceeds the TBR, the zero equilibrium is unstable, that is, the reintroduction of few infections can lead in the endemic state). The reasons for the existence of breakpoints are best explained by the mating process: as transmission depends on sexual reproduction of the parasite, an individual must harbor at least one female and one male parasite to contribute to the transmission of the infection. Averaged over the population, however, breakpoints do not necessarily remain at two parasites per host and can still be relevant for control measures if falling short of one parasite per host. The mating process transforms the process of microfilariae (Mf) production by adult female worms into a facilitation process because mating (and hence reproduction) becomes increasingly facilitated at high parasite burdens.

Control: Reduction of the incidence of infection to a certain level where the disease is no longer considered to be a public health problem.

Density-dependent processes: Regulatory processes in the vector–parasite–host relationship which depend in a nonlinear way on the parasite density – that is, the number of parasites per host (see also Facilitation and Limitation).

Elimination: Local reduction to zero of the incidence of infection; because infection can be imported from other areas that are still endemic, permanent intervention is required to maintain elimination as a stable state of the trivial equilibrium.

Equilibrium: A parasite density (e.g. adult parasites per host, microfilariae per mg skin snip, L3 per fly or ATP) which is sufficiently constant over a long period of time. The equilibrium solution of a mathematical model results from setting the derivatives equal to zero, such that there is no longer a change in the variables. The term 'trivial equilibrium' describes the zero equilibrium which is stable in the case of facilitation and unstable in the case of limitation (provided ABR > TBR; below the TBR the trivial equilibrium is stable). Positive unstable equilibria are synonyms for breakpoints.

Eradication: Global reduction to zero of the incidence of infection; once achieved, further interventions are not necessary (Eradicability is a term often used in a broader sense, without discriminating between the local and the global aspect).

Facilitation: A positive feedback process in which a parasite (at any stage) promotes the success of parasites at the same or another stage, regarding survival, development, reproductivity, etc. Because any population is limited in space, reproductivity, etc., a facilitation process must be associated with at least one 'stronger' limitation process. Facilitation processes increase transmission thresholds and breakpoints and thereby positively influence ('facilitate') the eradicability of an infection.

Limitation: A negative feedback process in which a parasite (at any stage) compromises the success of parasites at the same or another stage, regarding survival, development, reproductivity, etc. Because any population is limited in space, reproductivity, etc., limitation is the rule. However, it is possible that the limited part of the process is not yet, or might not be, observable. Limitation processes decrease transmission thresholds and breakpoints and thereby negatively influence ('limit') the eradicability of an infection.

L3: Third stage larva. This is the infectious parasite stage which can be transmitted from a fly to a human host during a bloodmeal. If the L3 survives the machanisms of host resistence or immunity, it develops into an adult worm via the fourth stage larva (L4). See also life cycle.

L4: Fourth larva stage, between the L3 and the adult parasite. In onchocerciasis, it is assumed that the period of development from the L3 into and adult parasite and thus, the lifespan of an L4, is about one year. See also life cycle.

PER: Parasite establishment rate, i.e. the number of adult female O. volvulus which establish in a human host per year.

Superinfection: In the context of filarial diseases, this term is used for describing the process of infection with a new parasite while being already infected with one or more parasites of the same species.

TBR: Threshold biting rate (an ABR below which the infection cannot persist). A more general term is transmission threshold.

Transmission threshold: A vector density below which infection cannot persist (see also TBR). If there are too few vectors, an adult parasite will die before any of its offspring are transmitted, and, consequently, the infection does not get transmitted. A key variable is the ABR. The threshold below which the infection cannot persist, the threshold biting rate (TBR), is a measure of the persistence of the parasite population. The values of the TBR vary considerably between parasite subspecies and depend on the density-dependent processes operating in vectors and hosts and on the heterogeneity in contact rates between vectors and hosts.

Responsible for this page: Dr. H.-P. Duerr
Webmaster: Prof. Dr. M. Eichner (last change of this page on 13 July 2009)
Disclaimer: Eberhard-Karls-University Tübingen, Tübingen University Hospital, the Department for Medical Biometry (IMB), and the authors of this page disclaim all liability for the content of any page referenced by hyper-link from this page

You are the  th visitor of our pages.